The Female Health Co announces new strategic direction, suspends dividends The company plans to suspend payment of quarterly dividends and devote cash flows towards strategic initiatives planned to accelerate company's long-term growth in revenue and earnings. It plans to invest in growing the market for the FC2 Female Condom. The company will also evaluate investments in new products, technologies and/or businesses that complement the core competencies and strengths of the Company. It believes the risks associated with a single product offering, along with the significant volatility in purchasing patterns for FC2, can be mitigated by the presence of a more diversified portfolio of business activities. The company may have the ability to utilize a portion of our operating cash flows to strategically buy back FHCO shares under the company's stock repurchase program.